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Abstract
Se is a micronutrient essential for human health. Sub-optimal Se status is common, occurring in a significant proportion of the population across
the world including parts of Europe and China. Human and animal studies have shown that Se status is a key determinant of the host response
to viral infections. In this review, we address the question whether Se intake is a factor in determining the severity of response to coronavirus
disease 2019 (COVID-19). Emphasis is placed on epidemiological and animal studies which suggest that Se affects host response to RNA viruses
and on the molecular mechanisms by which Se and selenoproteins modulate the inter-linked redox homeostasis, stress response and inflam-
matory response. Together these studies indicate that Se status is an important factor in determining the host response to viral infections.
Therefore, we conclude that Se status is likely to influence human response to the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection and that Se status is one (of several) risk factors which may impact on the outcome of SARS-CoV-2 infection, particularly
in populations where Se intake is sub-optimal or low. We suggest the use of appropriate markers to assess the Se status of COVID-19 patients
and possible supplementation may be beneficial in limiting the severity of symptoms, especially in countries where Se status is regarded as sub-
optimal.
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A link between Se deficiency and human disease was first dem-
onstrated by the discovery in China that the aetiology of Keshan
disease involved both coxsackievirus infection and a low intake
of the micronutrient Se(1,2). Since those initial observations, sev-
eral studies have investigated how Se intake affects responses to
viral infections(3) and the importance of understanding these
links is highlighted by the coronavirus disease 2019 (COVID-
19) pandemic(4). This is of particular relevance because,
although severe Se deficiency is rare, there is considerable evi-
dence that sub-optimal Se status is common with a significant
proportion of the population across the world potentially in this
category(5). Fish and shellfish are relatively high in Se content
but, for most foods, Se content is dependent on the level of Se
present in the soil; this geographical variation is reflected in the
Se status of different human populations, many of which have
blood Se that is regarded as sub-optimal (≤85 μg/l)(5,6), for exam-
ple, in parts of Europe including the UK.
Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is the infectious agent responsible for the current
COVID-19 pandemic. It is a coronavirus with a positive-sense
single-stranded RNA genome (26–32 kb), one of the largest of
the RNA viruses(7,8). Other clinically important RNA viruses
include those responsible for respiratory diseases, such as severe
acute respiratory syndrome (SARS), Middle East respiratory syn-
drome (MERS) and influenza, and for other infectious diseases
such as poliomyelitis and HIV infection(3). SARS-CoV-2 targets
cells expressing the angiotensin-converting enzyme 2 receptor;
these include airway epithelial cells, alveolar epithelial cells, vas-
cular endothelial cells and macrophages in the lung as well as
myocardial and renal cells(9,10). SARS-CoV-2 infection is
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characterised by a highly aggressive inflammatory response.
Pyroptosis of infected lung epithelial cells, as a result of viral rep-
lication, triggers an inflammatory cascade leading to the release of
pro-inflammatory cytokines and chemokines(9). The cytokine
storm (hypercytokinaemia) observed in severe cases induces
widespread damage to the lung epithelium that can facilitate
the development of secondary bacterial or fungal infections(11).
In addition to the local damage, the cytokine storm and uncon-
trolled inflammation affect other parts of the body, in particular
the myocardial and renal systems, and can lead to septic shock,
multi-organ failure and death(12,13).
The COVID-19 pandemic raises three major questions in
relation to Se: (i) to what extent does Se intake, particularly
sub-optimal intake as well as severe deficiency, affect responses
to viral infection; (ii) what are the biochemical mechanisms sup-
porting a role of Se in the host response and (iii) could Se intake
be a factor in determining the response to COVID-19 infection?
In this article, we address these questions by firstly reviewing the
literature concerning the effects of Se on RNA virus infections,
secondly by exploring how Se modulates the inter-linked redox
homeostasis, stress response and inflammatory response mech-
anisms and finally by considering these effects in relation to
recent observations on COVID-19.
Host selenium status and viral infection
The first evidence that there might be a link between Se status
and susceptibility of humans to a viral infection came from the
study of Keshan disease, amyocardiopathy associatedwith heart
failure and death, among the population in Heilongjiang prov-
ince in China(1). The Se content of food and drinking water
was found to be extremely low in areas where the disease
was endemic. Addition of Se-containing fertiliser to the soil
and direct nutritional supplementation led to a large reduction
in the incidence of the acute form of the disease(1,14).
However, the seasonal variation of the disease suggested addi-
tional contributing factors, and postmortem samples from
patients were found to contain the coxsackievirus B3 (CVB)
virus, a single-stranded RNA virus. It is now clear that Keshan
disease is due to a combination of infection with CVB and low
Se status. In mice, CVB can lead to myocarditis, inflammation
of the heart. The virulence of CVB strains varies and crucially
it was observed that a non-virulent strain, which caused no dis-
ease in animals fed a Se-adequate diet, caused severe myocardi-
tis in animals fed a Se-deficient diet(14). In addition, sequencing of
the viral genome revealed that passage through Se-deficient
mice led tomutations in the viral genetic sequence and increased
pathogenicity(15,16). Similarly, an influenza virus (IV) strain caus-
ing mild pneumonitis induced much greater pathogenicity in
Se-deficient mice(17,18). Furthermore, as with CVB, Se status also
affected IV mutation, with low Se status promoting rapid evolu-
tion in haemagglutinin (HA) and neuraminidase (NA) genes(19).
An in vitro study on bronchial epithelial cells showed that Se
supplementation lowered the extent of apoptotic cell death after
infection with IV(18).
Few data are available concerning the relationship between
Se status and HIV susceptibility or disease progression(3).
However, two studies indicate that sub-optimal Se status lowers
the number of CD4 T cells and increases both disease progres-
sion and death rates in HIV-infected patients(20,21). Se deficiency
is commonly observed in HIV-infected patients and has been
linked to increased mortality. In a study of 125 HIV-1 sero-
positive drug-using men and women, CD4 T cell counts over
time and Se deficiency (but not deficiency of vitamin A, vitamin
B12 or Zn) were significantly associatedwithmortality, indicating
that Se deficiency is an independent predictor of survival for
those with HIV-1 infection(21).
The incidence of haemorrhagic fever with renal syndrome, a
public health problem in China caused by RNA hantaviruses, is
about six times higher in severely Se-deficient areas of China
comparedwith non-Se-deficient areas, and negatively correlated
with the Se content of crops and feeds(22). Surprisingly, plasma
concentration and activity of the selenoprotein glutathione per-
oxidase 3 (GPX3) were significantly higher in haemorrhagic
fever with renal syndrome patients compared with controls,
but this may indicate increased inflammation rather than
differences in Se status. Finally, in vitro Se supplementation
(200 ng/ml) significantly lowered viral copy number in human
umbilical vein endothelial cells (HUVEC) infected with hanta-
virus at a low multiplicity of infection(22). Although no human
studies have assessed the impact of Se status on the disease asso-
ciated with West Nile virus, another RNA virus, in vitro infection
of kidney epithelial cells leads to lower virus-induced cell death
in Se-supplemented conditions(23).
The effects of Se supplementation on viral infection in
humans were studied in UK volunteers of marginal Se status
(plasma Se< 95 μg/l) who were given an attenuated polio virus.
Se supplementation was found to both increase the rate at which
the virus was cleared from the body and decrease the rate at
which mutations appeared in the viral genome(24). In addition,
measurements of immune markers indicated that supplemental
Se accelerated the cellular antiviral response. Importantly, this
study not only supports animal work on IV and CVB showing
that higher Se status enhanced the host response to a viral infec-
tion and promoted generation of mutations that increase viru-
lence of RNA viruses, but also provides evidence that similar
effects occur in humans within a range of Se status found com-
monly in the UK population and worldwide.
In summary, there is strong evidence that low Se status in
both animals and humans influences the host response to a num-
ber of RNA viruses with low Se status leading to more severe
forms of the disease. Furthermore, in CVB and IV infections,
low Se status also promotes generation of mutations and
increased virulence. The impact of Se status on the ability of a
host to respond to viral infection is reflected in the crucial role
of Se and selenoproteins in cellular and molecular mechanisms
involved in the control of redox homeostasis, stress response,
immune and inflammatory response.
Selenoproteins, cell stress response mechanisms and viral
infection
Dietary Se is converted in the body into the amino-acid seleno-
cysteine which is then incorporated into proteins,
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selenoproteins, during their synthesis by a unique mechanism
which involves a specific tRNA for selenocysteine and recoding
of a UGA stop codon as codon for selenocysteine(25,26). To date,
twenty-five genes coding for selenoproteins have been identi-
fied. The biological activity of Se is carried out primarily through
its presence in these selenoproteins, the functions of which
centre around roles in antioxidant protection, redox homeostasis
and endoplasmic reticulum (ER) stress(27) (Fig. 1). Thus, GPX1–4
have well-documented, important roles in the metabolism of,
and protection from, reactive oxygen species (ROS) including
peroxides and lipid hydroperoxides. Thioredoxin reductases
(TXNRD) function in redox homeostasis and signalling, and a
series of lesswell-characterised selenoproteins including seleno-
protein F, K, M, N and S (SELENOF, SELENOK, SELENOM,
SELENON and SELENOS) are present in the ER where they play
roles in protein folding and protection from oxidative stress. In
both human and mouse models, transcriptomic and proteomic
analyses have indicated that, in colonic tissue and leucocytes,
the major downstream target pathways affected by sub-optimal
Se intake are immune response and inflammatory signalling,
nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-κB) signalling and ER stress response pathways(28–30).
Such changes are consistent with the known roles of selenopro-
teins and highlight that changes in Se intake can affect the path-
ways that determine cell responses to oxidative and ER stress as
well as the immune response.
Oxidative stress response and redox homeostasis
Viral-induced oxidative stress through generation of ROS is cru-
cial to the viral lifecycle and its pathogenicity(31). Se, through the
activity of antioxidant selenoproteins, has the potential to
enhance the response to viral-induced oxidative stress and to
contribute to the maintenance of redox homeostasis. Se supple-
mentation, which increases GPX1 expression and lowers oxida-
tive stress in a cell culture model, reduces the replication rate of
porcine circovirus 2, a DNA virus(32). Data fromGM animal mod-
els (knock-out) show that, contrary to wild-type mice, animals
lacking GPX1 developed myocarditis when infected by a benign
CVB strain, in a similar manner to mice fed a Se-deficient diet(33).
Similarly, following IV infection, GPX1 knock-out mice dis-
played an increased and prolonged tissue inflammation, higher
levels of macrophages in bronchial fluid and higher levels of the
pro-inflammatory cytokine TNF-α; furthermore, some effects
were reversed by ebselen (2-phenyl-1,2-benzisoselenazol-
3(2 H)-one), a synthetic organoselenium compound/drug with
GPX-mimetic properties(34). Lower selenoprotein levels in mice
expressing a mutant selenocysteine tRNA gene were found to
alter the response to IV infection, with increased levels of lung
pro-inflammatory cytokines and interferon-γ (IFN-γ) and slow
viral clearance rates, although there was no effect on lung path-
ology(35). Since thesemice showed only a small 20 % reduction in
GPX1 expression, it is possible that there is a threshold activity of
GPX1 and other selenoproteins above which there is little effect
on virus infection. Overall, these data suggest that GPX1 is
important for appropriate cell and tissue responses to a viral
infection, in particular in relation to the inflammatory response
to respiratory viruses.
Changes in redox homeostasis, disruption of antioxidant
defences, chronically elevated levels of ROS and induction of
ROS-generating enzymes, such as NADPH oxidase (NOX) and
xanthine oxidase, are key events linked to infection with respi-
ratory viruses, including IV and SARS-CoV(31,36). Increased levels
of ROS and reactive nitrogen species have been reported in lung
Dietary Se
Selenoproteins















Fig. 1. Selenium and response to viral infection. In humans, dietary selenium is incorporated into twenty-five selenoproteins as the amino acid selenocysteine.
Selenoproteins include glutathione peroxidases (GPX), 15 kDa selenoprotein F (SELENOF), selenoproteins K and S and thioredoxin reductases (TXNRD). They play
crucial roles in molecular pathways such as oxidative stress response, redox control and mitochondrial function, as well as endoplasmic reticulum (ER) stress and
unfolded protein responses (UPR), and immune and inflammatory response in particular involving NF-κB and nuclear factor erythroid 2-related factor 2 (Nrf2) signalling.
Cross-talk between these pathways has been shown to be key to produce an adequate response to viral infections, and low selenium status has been linked to poorer
response to RNA virus infection in human studies, and animal and cell culture models. The diagram illustrates how reduced expression of selenoproteins as a result of
low/sub-optimal selenium status could alter molecular pathways involved in stress responses and contribute to an aggressive pro-inflammatory environment leading to
poorer disease prognosis.
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tissues of patients who died in fatal IV pandemics, while studies
with IV-infected mice and cell lines also demonstrated an
enhanced production of ROS and disturbance of antioxidant
defence(37–39). Suppression of chronic oxidative stress by target-
ing pro-oxidant enzymes such as NOX and dual oxidase
(DUOX) could, therefore, ameliorate host response to viral infec-
tion. At present, no evidence is available for a role of Se or sele-
noproteins in modulating NOX and DUOX activity in relation to
viral infections; however, supplementation with selenomethio-
nine has been shown to protect lung tissue against toxic effects
of ionising radiation by reducing DUOX1 and 2 gene expression
and IL-4 and IL-4 receptor subunit α-1 protein levels(40).
Moreover, GPX and TXNRD have been shown, in endothelial
cells, to play an important role in controlling the metabolism
and physiological function of ROS and reactive nitrogen species,
whose production is regulated by NOX and xanthine oxidase(41).
Control of ROS levels associated with endothelial damage and
inflammation may provide a potential mechanism by which Se
status modulates the host response to viral infection, and this
could be significant in the case of SARS-CoV-2 infection as both
endothelial damage and inflammation have been linked to
COVID-19 aetiology(42).
As a first line of defence, epithelial barriers often undergo
significant damage as a result of the release/production of
ROS. Through their antioxidant functions, selenoenzymes such
as GPX protect epithelial barriers from ROS by reducing lipid
and phospholipid hydroperoxides, and thus, adequate Se status
could also contribute to the maintenance of the structural and
functional integrity of respiratory epithelial barriers. Similarly,
antioxidant selenoproteins protect neutrophils from endog-
enous oxidative stress(43).
Mitochondrial dysfunction has also been linked to viral infec-
tion. In IV infection, mitochondria are an important source of
ROS due to the virus-induced leakage of electrons from the res-
piratory chain(44). Similarly, a study by Shi et al.(45) reported that a
protein encoded by SARS-CoV, designated as open reading
frame-9b (ORF-9b), localised to mitochondria and caused mito-
chondrial elongation, resulting in evasion of host innate immun-
ity. Although to date there is no evidence that during respiratory
virus infection the alteration of mitochondrial function is caused
by lower selenoprotein expression, a considerable amount of
data indicates that selenoproteins such as GPX4, GPX1 and
TXNRD1 are crucial to maintain mitochondrial function and
redox homeostasis(46,47). Thus, low Se status has the potential
to affect response to respiratory viruses by impacting on the
expression of selenoproteins key to mitochondrial
function (Fig. 1).
Endoplasmic reticulum stress
The ER is important for protein synthesis, folding, processing and
post-translational modifications. During viral infections, the pro-
tein load exceeds the ER folding and processing capacity, and
activation of various signalling pathways, collectively known
as ER stress response or unfolded protein response (UPR),
occurs as part of the host antiviral response(48). ER redox state,
ER stress and Ca2þ signalling are tightly regulated by a complex
antioxidant system, which includes seven ER-resident
selenoproteins – 15 kDa selenoprotein (SELENOF), type 2 iodo-
thyronine deiodinase (DIO2) and SELENOS, N, K, M and T
(Fig. 1). As a group, they are implicated in a range of processes
including ER stress and inflammation (reviewed in Addinsall
et al.(49)). Cross-talks between ER function, NF-κB signalling
and mitochondrial function(50) during immune response and
antiviral defence highlight that these mechanisms are inter-
linked (Fig. 1). More specifically, in Z α(1)-antitrypsin (ZAAT)
deficiency, a disease associated with emphysematous lung
disease, SELENOS was found to affect ER function and NF-κB
signalling, and this effect was enhanced following Se supple-
mentation(51). In addition, silencing of SELENOS in vascular
smooth muscle cells, enhanced markers of ER stress suggesting
that SELENOS might protect cells by inhibiting oxidative and ER
stress(52). Mice with targeted deletion of SELENOK exhibited
decreased viral clearance and elevated viral titres in the brain
uponWest Nile virus infection. Interestingly, these mice showed
decreased Ca2þ flux in the ER of T cells, macrophages and neu-
trophils and lower T cell proliferation suggesting a role for
SELENOK in immune response(53). In human volunteers,
SELENOS expression in peripheral blood mononuclear cells
was found to increase after an IV challenge, and furthermore this
increase was enhanced after Se supplementation(54).
These findings, although not all closely related to respiratory
viral infections, demonstrate several roles for selenoproteins in
regulating ER stress and suggest they are important in determin-
ing ER stress and inflammatory responses during viral infections.
SARS-CoV accessory viral protein affects several UPR compo-
nents, suggesting that such viruses may directly modulate ER
stress responses(55). Since ER stress and inflammation are
inter-linked(56), it is likely that UPR induction may play a signifi-
cant role in the host response to SARS-CoV-2. Furthermore, there
is a close relationship between ER stress, oxidative stress and
inflammation. ER stress can lead to inflammation and conversely
inflammation can induce UPR and ER stress(56). High production
of free radicals by immune cells, especially macrophages, at the
site of infection, triggers oxidative stress. Excessive extracellular
ROS/reactive nitrogen species initiates signalling cascades that
lead to the onset of the inflammatory response, generating
inflammatory mediators such as IL-1β, IL-6 and TNF-α and acti-
vating NF-κB signalling pathways(57–60).
Selenium, inflammation, immune response and viral
infections
As described in the above sections, there is extensive evidence
suggesting that the inter-linked biochemical pathways of oxida-
tive stress, ER stress and inflammation are induced during viral
infection. This is true for a number of respiratory viruses and
the limited data concerning SARS-CoV and SARS-CoV-2 indicate
that they affect these pathways. Lung cell lines infected with
either SARS-CoV-2, IV or MERS-CoV showed that up-regulation
of antiviral IFN signalling was observed with all three viral infec-
tions, whereas up-regulation of the cytokine/inflammatory proc-
esses, down-regulation of mitochondrial organisation and
respiration processes, and perturbation in the autophagic proc-
esses were specifically observed in SARS-CoV-2-infected cells
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and were absent in IV-infected cells(61). These data highlight that,
in SARS-CoV-2 infection, both mitochondrial function and inflam-
matory signalling were affected, which in turn could affect the
immune response and lead to severe outcomes in the host.
In infections caused by SARS-CoV or SARS-CoV-2, pro-
nounced inflammation and increased secretion of IL-1β, IL-4,
IL-10, IFN-γ, IFN-γ-induced protein 10 (IP-10) and monocyte
chemoattractant protein 1 (MCP-1) were observed(4,62). In addi-
tion, production of several NF-κB-mediated cytokines, including
IL-6 and IL-8, has been detected in human bronchial epithelial
cells in response to SARS-CoV infection(63), whereas patients
with severe COVID-19 in intensive care units exhibit elevated
plasma levels of several cytokines (IL-2, IL-7, IL-10, TNF-α,
MCP-1, granulocyte-colony stimulating factor (GCSF), IP-10
and macrophage inflammatory proteins (MIP1A)), suggesting
a cytokine storm, resulting in hyper-inflammation(64).
Furthermore, evidence exists for IV strains to activate the nuclear
factor erythroid 2-related factor 2/antioxidant response element
(Nrf2/ARE) defence pathway, in vitro and in mice, subsequently
leading to the activation of the NF-κB pathway and cytokine pro-
duction(65,66), suggesting a potential important role for the Nrf2-
NF-κB cross-talk in associated pathogenesis, even if further evi-
dence is required for other respiratory viruses.
Moderate Se deficiency was found to activate Nrf2 and the
Wnt pathways which may have negative effects on protection
against oxidative stress and inflammation in cancer cell
models(67); in addition, TXNRD1 has been shown to be a potent
regulator of Nrf2 activation in lung epithelial cells(68). Using a
combined transcriptomics and proteomics approach to analyse
gene and protein expression in rectal biopsies of healthy individ-
uals, sub-optimal Se status was found to be associated with
inhibition of NF-κB, IL-1β, IL-6 and TNF-α signalling and
down-regulation of immune and inflammatory response path-
ways(30). Similar effects were observed in the colon of mice
fed a mildly deficient Se diet(28). In mice, a genomic approach
combined with cytokine measurements has shown that a low
Se diet led to increased activity of IFN-γ and IL-6 pathways as
well as IL-6 levels(69). Furthermore, following a lipopolysaccha-
ride challenge, IL-6 levels were found to be greater in mice fed a
low Se diet(70), while, in women, lower Se status was associated
with higher plasma IL-6 levels(71). In addition, uncontrolled
inflammation is associatedwith an altered balance of pro-inflam-
matory and anti-inflammatory eicosanoids. Animal studies have
shown that increased Se intake leads to a rebalance towards
more anti-inflammatory eicosanoids(72), probably through
modulation of lipoxygenase and cyclooxygenase activities as a
result of increased GPX activity lowering levels of hydroperox-
ides and lipid radicals and so altering peroxide tone. Increased
Se intake also causes lower expression of pro-inflammatory
NF-κB signalling(73). There is also evidence for epigenetic regu-
lation of inflammatory gene expression by Se(74). Overall, Se
intake affects a range of inflammatory mechanisms including
Nrf2, eicosanoid and NF-κB signalling pathways(30,67,68,72,73)
and therefore, individuals with sub-optimal/low Se status may
exhibit an inadequate inflammatory response to respiratory
RNA viral infections.
Alongside inflammation, SARS-CoV-2 infection triggers a
local immune response, recruiting macrophages and monocytes
that respond to the infection, release cytokines and prime adap-
tive T and B cell immune responses(9). In particular, the immune
response induced by SARS-CoV-2 infection is two phased: an ini-
tial phase in which specific adaptive immune responses are
required to eliminate the virus and to preclude disease progres-
sion to the second andmore severe phase that is characterised by
severe lung damage (e.g. acute respiratory distress syndrome)
and in which suppression of inflammation may be beneficial(75).
Therefore, strategies to boost immune responses are certainly
important as, in some cases, a dysfunctional immune response
occurs, which can cause severe lung and even systemic
pathology.
Adequate Se levels have been shown to be required for the
differentiation and proliferation of a number of immune cells
involved in innate and adaptive immunity. In particular, at mod-
erate doses, Se supplementation increases T cell proliferation
and natural killer cell activity(76,77). Moreover, Se supplementa-
tion of individuals with marginally low plasma levels increased
cellular immune response to live polio vaccine and virus
clearance(24); although Se supplementation did not directly affect
antibody titre after flu vaccination(78), supplementation of indi-
viduals with marginally low Se status (92–98 μg/l) resulted in
some beneficial effect on cellular immunity, with significantly
higher T cell proliferation in the group supplemented with
100 μg/d selenomethionine in yeast matrix(78). However, higher
supplementation doses (200 μg/d selenomethionine in yeast
matrix) led to a reduction in granzyme positive CD8 cells, and
other forms of Se (e.g. Se-onions) did not impact on the immune
response to flu vaccination(78). These data complement the
review by Steinbrenner and colleagues(79) and suggest that opti-
mising plasma Se status may improve immune responses, but
high supplemental doses may have detrimental effects.
Finally, as part of the innate immune response to pathogens,
the methionine sulfoxide reductase B1 (MSRB1) selenoenzyme
has been found, in murine macrophages, to regulate, through a
redox mechanism and remodelling of the actin cytoskeleton,
macrophage activation and phagocytosis(80) and to promote
anti-inflammatory cytokine production; the ablation of the
MSRB1 gene induced instead excessive pro-inflammatory cyto-
kine production(81).
Selenium status and COVID-19
The available data suggest that several respiratory viruses induce
changes in redox, ER stress and inflammation pathways that may
bemodulated by Se or selenoproteins. It appears that SARS-CoV-
2 may induce comparable changes in these pathways but, to
date, it is not known whether low Se status modulates the effect
of the virus on such pathways and so enhances the cytokine
storm observed in severe cases of COVID-19. Future studies
should address whether this is the case, using both relevant ani-
mal and cell models and by assessing Se status and plasma
inflammatory markers of patients with severe v. mild forms.
Blood levels of SELENOP, themajor form of Se in blood, are low-
ered by inflammation making the use of appropriate markers of
Se status such as hair Se or erythrocyte Se important in human
studies(82,83). Such studies could inform the potential use of Se
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supplementation to limit the inflammatory response of patients
(Fig. 2).
It is widely accepted that SARS-CoV-2 originated in Wuhan,
Hubei province in China and rapidly spread across Hubei prov-
ince and, subsequently, globally. Prior to the emergence of
SARS-CoV-2, the population of Hubei was reported to show a
wide range of hair Se content (0·06–0·79 mg/kg), albeit with a
small sample size(84). This wide range is compatible with both
Se deficiency perhaps not being uncommon in Hubei province
and there also being known high-Se areas. Interestingly, a recent
ecological analysis using these data in relation to the COVID-19
outbreak in China indicates that there may be a relationship
between Se status and disease outcome(85). Cure and death rates
from COVID-19 were analysed in different regions in relation to
Se status as previously assessed by hair Se; notably, the city of
Enshi in Hubei province, known for high Se status, showed a sig-
nificantly higher cure rate, whereas Heilongjiang province,
known to be an area of low Se status, showed a higher death rate.
Overall, cure rate was associated with higher Se status. Although
the association described in the present study is not based
directly on Se status in COVID-19 patients, the work highlights
that further, more detailed studies of Se status, COVID-19 infec-
tion and disease outcomes are vitally important. In addition,
since levels of Se reported in some of the areas relevant to the
present study are higher than those needed to optimise seleno-
protein activities such future studies should address the range of
Se intake effective at giving any protection.
Worst disease outcomes and higher mortality for COVID-19
patients have been associated with age, as well as other morbid-
ities including obesity, type 2 diabetes and cardiovascular disor-
ders that are often characterised bymalnutrition(86) and immune-
compromised individuals (Fig. 2). Low levels, or intakes, of
micronutrients including Se, Zn and vitamins A, B6, B12 and E
have been linked to adverse outcomes in viral infection(87)
and levels of these micronutrients, as well as vitamins C
and D, n-3 PUFA and iron should be considered in COVID-19
patients(88). Obesity and high BMI have been found to be asso-
ciated with severe forms of COVID-19(89,90), possibly due to
obesity-induced chronic inflammation. Potential explanations
for these findings could include poor nutritional status of obese
individuals, pre-existing impaired immune response or ampli-
fied pro-inflammatory responses and/or high affinity of SARS-
CoV-2 for angiotensin-converting enzyme 2 (ACE2) receptor,
highly expressed in adipose tissue(91,92). Similarly, obesity has
been shown to increase the duration of IV shedding and to be an
independent risk factor for hospitalisation and death in H1N1
influenza(93,94), and it has been suggested that the adipose tissue
could represent a reservoir for SARS-CoV-2, IV and HIV(89,95).
Furthermore, several studies indicate that Se levels are lower
in obese individuals and a recent systematic review confirmed
both that mean levels of Se in blood/serum were lower in the
obese compared with healthy adult subjects and that mean
blood GPX activity was decreased in obese individuals(96).
Interestingly, the authors reported that Se levels were higher
in subjects with the metabolic syndrome.
Se derivative compounds have also been used as therapeutic
agents. In particular, the organoselenium compound ebselen
exhibits antioxidant properties, as well as anti-inflammatory, and
anti-bacterial and antiviral properties(97). Recently, using a combina-
tion of virtual and high-throughput technologies to screen 10 000
compounds, ebselen was identified among the most efficient
potential inhibitor against COVID-19 main protease (Mpro) and
demonstrated strong antiviral activity in cell-based assays(98,99).
As clinical trials have shown ebselen can be safely used in
humans(100,101), this compound represents an interesting potential
therapeutic candidate for COVID-19 (Fig. 2).
Given the strong evidence that Se protects against viral infec-
tion and supports an adequate immune response, it seems that
individuals with low Se status could benefit from supplemental
Se to prevent the development of severe forms of COVID-19.
However, considering the ongoing debate around the risk-


















Fig. 2. Hypothetical model of the impact of selenium on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Disease outcome of a coronavirus
disease 2019 (COVID-19) patient is influenced by age, obesity and the presence of co-morbidities such as type 2 diabetes (T2D), CVD and by being immunocompro-
mised. Based on the current knowledge of the effects of selenium status on RNA virus infections, it can be speculated that patients with low/sub-optimal selenium status
and reduced selenoprotein expression could be at higher risk of poor disease outcome. This could be influenced not only by dietary intake but also by genotype for a
number of genetic variants in selenoprotein genes. Nutritional intervention such as selenium supplementation with selenomethionine (SeMet) or sodium selenite
(Na2SeO3) may therefore improve disease outcomes for individuals with sub-optimal selenium status. Furthermore, therapeutic interventionsmay also include synthetic
selenium compounds such as ebselen that has been found to inhibit SARS-CoV-2 main protease (Mpro). ACE2, angiotensin-converting enzyme 2.
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should be restricted to individuals with low or sub-optimal Se
intake/status to avoid toxicity associated with high Se intake.
Since a number of SNP in genes encoding selenoproteins have
been found to have functional consequences for Se metabolism
and risk for a number ofmultifactorial diseases(26), it is possible that
genetic factors may also influence any effect of Se status on viral
infection progression. As regards selenoproteins’ importance in
redox homeostasis or ER stress response, a variant in the
SELENOS gene has been reported to affect levels of inflammatory
cytokines(102), one in GPX4 to affect monocyte adhesion to endo-
thelial cells(103) and others to affect inflammatory disease and
cancer risk. It is interesting to speculate that suchgenetic variations,
in combination with Se status, may impact on the ability of an
individual to produce an adequate immune response to, and com-
bat oxidative stress that occurs during viral infection (Fig. 2).
Although to date no SNP in a Se pathway have been linked to
altered response to infectious pathogens, other genetic variants
in key host immune response genes in the host immune system
havebeen shown tomodulate bothdiseaseoutcomeand response
to vaccination(104).
An additional link, albeit novel and speculative, between
SARS-CoV-2 and Se metabolism is through the mechanism of
nonsense-mediated RNA decay. Coronaviruses, of which
SARS-CoV-2 is one, have been reported to interfere with non-
sense-mediated RNA decay(105), a cellular mechanism that is also
thought to play a role in regulating the pattern of synthesis of
selenoproteins(106,107). It can, therefore, be envisaged that
SARS-CoV-2 infection may alter selenoprotein metabolism and
thus the effects of Se on various downstream functions: an effect
that would be exacerbated if Se intake is low. Future research
should investigate this relationship.
Conclusions
A better understanding of the immune and inflammatory
responses that occur during COVID-19 is essential to develop
adequate therapeutic approaches. Clearly, there are many fac-
tors that influence the response to SARS-CoV-2 infection and
the subsequent disease outcomes. Given the crucial role of nutri-
tion, and in particular micronutrients such as Se, in the immune
and inflammatory responses(88,108–110), it is also fundamental to
understand how nutritional status could influence the ability
to respond to the SARS-CoV-2. The significant body of evidence
from human, animal and cell culture studies indicates that Se sta-
tus is an important factor in response to viral infections, notably
RNA viral infections and including respiratory virus infections.
Understanding of these effects is strengthened by knowledge
of the underlying biochemical mechanisms discussed in this
review and together indicate that Se status may also influence
human response to the SARS-CoV2 infection. The one limited
study to date suggests that Se status is indeed associated with
COVID-19 disease outcome(85) and, therefore, we propose that
Se status is an additional risk factor that should be considered
as a determinant of SARS-CoV2 infection outcome, particularly
in populations where Se intake is sub-optimal or low.
Susceptibility to SARS-CoV2 infection is dependent on many fac-
tors such as age, BMI, obesity, type 2 diabetes and cardiovascular
dysfunction, and in this context of COVID-19 progression being
multifactorial, the relative importance of Se status remains to be
determined. However, we suggest that the use of appropriate
markers such as erythrocyte Se(83) to monitor Se status of
COVID-19 patients and possible supplementation may be ben-
eficial in limiting the severity of symptoms, and secondly that
authorities in countries where Se status is regarded as sub-
optimal may consider Se supplementation as a public health
strategy. Finally, on the basis of findings with other RNA viruses,
it will be important to assess the extent to which Se status affects
the mutation rate and pathogenicity of SARS-CoV-2.
Acknowledgements
The authors thank Robert Gordon University and Newcastle
University for supporting this work.
No financial support was received for this work.
G. B., C. M., D. K.M. and J. E. H. contributed to the conception
and design of this review, drafting and revising of the article.
G. B., C. M., D. K. M. and J. E. H. approved the final version.
The authors declare that there are no conflicts of interest.
References
1. Loscalzo J (2014) Keshan disease, selenium deficiency, and
the selenoproteome. N Engl J Med 370, 1756–1760.
2. Rayman MP (2000) The importance of selenium to human
health. Lancet 356, 233–241.
3. Guillin OM, Vindry C, Ohlmann T, et al. (2019) Selenium, sele-
noproteins and viral infection. Nutrients 11, 2101.
4. Huang C, Wang Y, Li X, et al. (2020) Clinical features of
patients infected with 2019 novel coronavirus in Wuhan,
China. Lancet 395, 497–506.
5. RaymanMP&RaymanMP (2002) The argument for increasing
selenium intake. Proc Nutr Soc 61, 203–215.
6. Johnson CC, Fordyce FM & Rayman MP (2010) Symposium on
‘Geographical and geological influences on nutrition’: factors
controlling the distribution of selenium in the environment and
their impact on health and nutrition. Proc Nutr Soc 69, 119–132.
7. Almeida JD, Berry DM, Cunningham CH, et al. (1968)
Virology: coronaviruses. Nature 220, 650.
8. Coronaviridae Study Group of the International Committee on
Taxonomy of Viruses (2020) The species severe acute respi-
ratory syndrome-related coronavirus: classifying 2019-nCoV
and naming it SARS-CoV-2. Nat Microbiol 5, 536–544.
9. Tay MZ, Poh CM, Renia L, et al. (2020) The trinity of
COVID-19: immunity, inflammation and intervention. Nat
Rev Immunol 20, 363–374.
10. Xu H, Zhong L, Deng J, et al. (2020) High expression of ACE2
receptor of 2019-nCoV on the epithelial cells of oral mucosa.
Int J Oral Sci 12, 8–12.
11. Chen N, Zhou M, Dong X, et al. (2020) Epidemiological and
clinical characteristics of 99 cases of 2019 novel coronavirus
pneumonia in Wuhan, China: a descriptive study. Lancet
395, 507–513.
12. Chu KH, Tsang WK, Tang CS, et al. (2005) Acute renal impair-
ment in coronavirus-associated severe acute respiratory syn-
drome. Kidney Int 67, 698–705.
13. Ruan Q, Yang K, Wang W, et al. (2020) Clinical predictors of
mortality due to COVID-19 based on an analysis of data of 150
patients fromWuhan, China. Intensive Care Med 46, 846–848.








bridge.org/core . Robert G
ordon U
niversity , on 15 Feb 2021 at 09:30:20 , subject to the Cam
bridge Core term






14. Beck MA, Levander OA&Handy J (2003) Selenium deficiency
and viral infection. J Nutr 133, 1463S–1467S.
15. Beck MA, Shi Q, Morris VC, et al. (1995) Rapid genomic evo-
lution of a non-virulent coxsackievirus B3 in selenium-
deficient mice results in selection of identical virulent isolates.
Nat Med 1, 433–436.
16. Beck MA (1997) Rapid genomic evolution of a non-virulent
coxsackievirus B3 in selenium-deficient mice. Biomed
Environ Sci 10, 307–315.
17. Beck MA, Nelson HK, Shi Q, et al. (2001) Selenium deficiency
increases the pathology of an influenza virus infection. FASEB J
15, 1481–1483.
18. Jaspers I, Zhang W, Brighton LE, et al. (2007) Selenium defi-
ciency alters epithelial cell morphology and responses to
influenza. Free Radic Biol Med 42, 1826–1837.
19. Nelson HK, Shi Q, Van Dael P, et al. (2001) Host nutritional
selenium status as a driving force for influenza virus muta-
tions. FASEB J 15, 1846–1848.
20. Look MP, Rockstroh JK, Rao GS, et al. (1997) Serum selenium
versus lymphocyte subsets and markers of disease progres-
sion and inflammatory response in human immunodeficiency
virus-1 infection. Biol Trace Elem Res 56, 31–41.
21. Baum MK, Shor-Posner G, Lai S, et al. (1997) High risk of
HIV-related mortality is associated with selenium deficiency.
J Acquir Immune Defic Syndr Hum Retrovirol 15, 370–374.
22. Fang LQ, Goeijenbier M, Zuo SQ, et al. (2015) The association
between hantavirus infection and selenium deficiency in
mainland China. Viruses 7, 333–351.
23. Verma S, Molina Y, Lo YY, et al. (2008) In vitro effects of
selenium deficiency on West Nile virus replication and cyto-
pathogenicity. Virol J 5, 66.
24. Broome CS, McArdle F, Kyle JA, et al. (2004) An increase in
selenium intake improves immune function and poliovirus
handling in adults with marginal selenium status. Am J Clin
Nutr 80, 154–162.
25. Hesketh J (2008) Nutrigenomics and selenium: gene expres-
sion patterns, physiological targets, and genetics. Annu Rev
Nutr 28, 157–177.
26. Meplan C (2015) Selenium and chronic diseases: a nutritional
genomics perspective. Nutrients 7, 3621–3651.
27. Bellinger FP, Raman AV, Reeves MA, et al. (2009) Regulation
and function of selenoproteins in human disease. Biochem J
422, 11–22.
28. Kipp A, Banning A, van Schothorst EM, et al. (2009) Four
selenoproteins, protein biosynthesis, and Wnt signalling are
particularly sensitive to limited selenium intake in mouse
colon. Mol Nutr Food Res 53, 1561–1572.
29. Kipp AP, Banning A, van Schothorst EM, et al. (2012) Marginal
selenium deficiency down-regulates inflammation-related genes
insplenic leukocytesof themouse. JNutrBiochem23,1170–1177.
30. Meplan C, Johnson IT, Polley AC, et al. (2016) Transcriptomics
and proteomics show that selenium affects inflammation,
cytoskeleton, and cancer pathways in human rectal biopsies.
FASEB J 30, 2812–2825.
31. Khomich OA, Kochetkov SN, Bartosch B, et al. (2018) Redox
Biology of Respiratory Viral Infections. Viruses 10, 392.
32. Chen X, Ren F, Hesketh J, et al. (2012) Selenium blocks
porcine circovirus type 2 replication promotion induced by
oxidative stress by improving GPx1 expression. Free Radic
Biol Med 53, 395–405.
33. Beck MA, Esworthy RS, Ho YS, et al. (1998) Glutathione per-
oxidase protects mice from viral-inducedmyocarditis. FASEB J
12, 1143–1149.
34. Yatmaz S, SeowHJ, Gualano RC, et al. (2013) Glutathione per-
oxidase-1 reduces influenza A virus-induced lung inflamma-
tion. Am J Respir Cell Mol Biol 48, 17–26.
35. Sheridan PA, Zhong N, Carlson BA, et al. (2007) Decreased
selenoprotein expression alters the immune response during
influenza virus infection in mice. J Nutr 137, 1466–1471.
36. Pohanka M (2013) Role of oxidative stress in infectious dis-
eases. A review. Folia Microbiol (Praha) 58, 503–513.
37. Buffinton GD, Christen S, Peterhans E, et al. (1992) Oxidative
stress in lungs of mice infected with influenza A virus. Free
Radic Res Commun 16, 99–110.
38. Hennet T, Peterhans E & Stocker R (1992) Alterations in anti-
oxidant defences in lung and liver of mice infected with influ-
enza A virus. J Gen Virol 73, 39–46.
39. Amatore D, Sgarbanti R, Aquilano K, et al. (2015) Influenza
virus replication in lung epithelial cells depends on redox-
sensitive pathways activated by NOX4-derived ROS. Cell
Microbiol 17, 131–145.
40. Amini P, Kolivand S, Saffar H, et al. (2019) Protective effect of
selenium-L-methionine on radiation-induced acute pneumo-
nitis and lung fibrosis in Rat. Curr Clin Pharmacol 14, 157–
164.
41. Brigelius-Flohe R, Banning A & Schnurr K (2003) Selenium-
dependent enzymes in endothelial cell function. Antioxid
Redox Signal 5, 205–215.
42. Varga Z, Flammer AJ, Steiger P, et al. (2020) Endothelial
cell infection and endotheliitis in COVID-19. Lancet 395,
1417–1418.
43. Kose SA & Naziroglu M (2014) Selenium reduces oxidative
stress and calcium entry through TRPV1 channels in the neu-
trophils of patients with polycystic ovary syndrome.Biol Trace
Elem Res 158, 136–142.
44. Kim S, Kim M, Park DY, et al. (2015) Mitochondrial reactive
oxygen species modulate innate immune response to influ-
enza A virus in human nasal epithelium. Antivir Res 119,
78–83.
45. Shi CS, Qi HY, Boularan C, et al. (2014) SARS-coronavirus
open reading frame-9b suppresses innate immunity by target-
ing mitochondria and the MAVS/TRAF3/TRAF6 signalosome.
J Immunol 193, 3080–3089.
46. Handy DE, Lubos E, Yang Y, et al. (2009) Glutathione peroxi-
dase-1 regulates mitochondrial function to modulate redox-
dependent cellular responses. J Biol Chem 284, 11913–11921.
47. Cole-Ezea P, SwanD, Shanley D, et al. (2012) Glutathione per-
oxidase 4 has a major role in protecting mitochondria from
oxidative damage and maintaining oxidative phosphorylation
complexes in gut epithelial cells. Free Radic Biol Med 53,
488–497.
48. Fung TS, Huang M & Liu DX (2014) Coronavirus-induced ER
stress response and its involvement in regulation of coronavi-
rus–host interactions. Virus Res 194, 110–123.
49. Addinsall AB, Wright CR, Andrikopoulos S, et al. (2018)
Emerging roles of endoplasmic reticulum-resident selenopro-
teins in the regulation of cellular stress responses and
the implications for metabolic disease. Biochem J 475,
1037–1057.
50. Namgaladze D, Khodzhaeva V & Brune B (2019) ER-mito-
chondria communication in cells of the innate immune sys-
tem. Cells 8, 1088.
51. Kelly E, Greene CM, Carroll TP, et al. (2009) Selenoprotein
S/SEPS1 modifies endoplasmic reticulum stress in Z variant
alpha1-antitrypsin deficiency. J Biol Chem 284, 16891–16897.
52. Ye Y, Fu F, Li X, et al. (2016) Selenoprotein S is highly
expressed in the blood vessels and prevents vascular smooth
muscle cells from apoptosis. J Cell Biochem 117, 106–117.
53. Verma S, Hoffmann FW, Kumar M, et al. (2011) Selenoprotein
K knockout mice exhibit deficient calcium flux in immune
cells and impaired immune responses. J Immunol 186,
2127–2137.








bridge.org/core . Robert G
ordon U
niversity , on 15 Feb 2021 at 09:30:20 , subject to the Cam
bridge Core term






54. Goldson AJ, Fairweather-Tait SJ, Armah CN, et al. (2011)
Effects of selenium supplementation on selenoprotein gene
expression and response to influenza vaccine challenge: a
randomised controlled trial. PLoS ONE 6, e14771.
55. Minakshi R, Padhan K, Rani M, et al. (2009) The SARS corona-
virus 3a protein causes endoplasmic reticulum stress and
induces ligand-independent downregulation of the type 1
interferon receptor. PLoS ONE 4, e8342.
56. Hasnain SZ, Lourie R, Das I, et al. (2012) The interplay
between endoplasmic reticulum stress and inflammation.
Immunol Cell Biol 90, 260–270.
57. Kaminska B (2005) MAPK signalling pathways as molecular
targets for anti-inflammatory therapy – from molecular mech-
anisms to therapeutic benefits. Biochim Biophys Acta 1754,
253–262.
58. Girard S, Kadhim H, Roy M, et al. (2009) Role of perinatal
inflammation in cerebral palsy. Pediatr Neurol 40, 168–174.
59. Hendrayani SF, Al-Harbi B, Al-Ansari MM, et al. (2016) The
inflammatory/cancer-related IL-6/STAT3/NF-kappaB positive
feedback loop includes AUF1 andmaintains the active state of
breast myofibroblasts. Oncotarget 7, 41974–41985.
60. Kyriakis JM & Avruch J (2001) Mammalian mitogen-activated
protein kinase signal transduction pathways activated by
stress and inflammation. Physiol Rev 81, 807–869.
61. Singh K, Chen YC, Judy JT, et al. (2020) Network analysis and
transcriptome profiling identify autophagic andmitochondrial
dysfunctions in SARS-CoV-2. Infection. https://doi.org/10.
1101/2020.05.13.092536.
62. Wong CK, Lam CW,Wu AK, et al. (2004) Plasma inflammatory
cytokines and chemokines in severe acute respiratory syn-
drome. Clin Exp Immunol 136, 95–103.
63. Yoshikawa T, Hill T, Li K, et al. (2009) Severe acute respiratory
syndrome (SARS) coronavirus-induced lung epithelial cyto-
kines exacerbate SARS pathogenesis by modulating intrinsic
functions of monocyte-derived macrophages and dendritic
cells. J Virol 83, 3039–3048.
64. Fu Y, Cheng Y & Wu Y (2020) Understanding SARS-CoV-2-
mediated inflammatory responses: from mechanisms to
potential therapeutic tools. Virol Sin 35, 266–271
65. Kosmider B, Messier EM, Janssen WJ, et al. (2012) Nrf2 pro-
tects human alveolar epithelial cells against injury induced
by influenza A virus. Respir Res 13, 43–43.
66. Yamada Y, Limmon GV, Zheng D, et al. (2012) Major shifts in
the spatio-temporal distribution of lung antioxidant enzymes
during influenza pneumonia. PLOS ONE 7, e31494.
67. Brigelius-Flohe R & Kipp AP (2013) Selenium in the redox
regulation of the Nrf2 and the Wnt pathway. Methods
Enzymol 527, 65–86.
68. Tindell R, Wall SB, Li Q, et al. (2018) Selenium supplementa-
tion of lung epithelial cells enhances nuclear factor E2-related
factor 2 (Nrf2) activation following thioredoxin reductase
inhibition. Redox Biol 19, 331–338.
69. Tsuji PA, Carlson BA, Anderson CB, et al. (2015) Dietary
selenium levels affect selenoprotein expression and support
the interferon-gamma and IL-6 immune response pathways
in mice. Nutrients 7, 6529–6549.
70. Berg BM, Godbout JP, Chen J, et al. (2005) Alpha-tocopherol
and selenium facilitate recovery from lipopolysaccharide-
induced sickness in aged mice. J Nutr 135, 1157–1163.
71. Walston J, Xue Q, Semba RD, et al. (2006) Serum antioxidants,
inflammation, and total mortality in older women. Am J
Epidemiol 163, 18–26.
72. Mattmiller SA, Carlson BA & Sordillo LM (2013) Regulation of
inflammation by selenium and selenoproteins: impact on
eicosanoid biosynthesis. J Nutr Sci 2, e28.
73. Hu Y, McIntosh GH, Le Leu RK, et al. (2016) Supplementation
with Brazil nuts and green tea extract regulates targeted bio-
markers related to colorectal cancer risk in humans. Br J Nutr
116, 1901–1911.
74. Narayan V, Ravindra KC, Liao C, et al. (2015) Epigenetic regu-
lation of inflammatory gene expression in macrophages by
selenium. J Nutr Biochem 26, 138–145.
75. Shi Y, Wang Y, Shao C, et al. (2020) COVID-19 infection: the
perspectives on immune responses. Cell Death Differ 27,
1451–1454.
76. Huang Z, Rose AH & Hoffmann PR (2012) The role of
selenium in inflammation and immunity: from molecular
mechanisms to therapeutic opportunities. Antioxid Redox
Signal 16, 705–743.
77. Maggini S, Pierre A & Calder PC (2018) Immune function and
micronutrient requirements change over the life course.
Nutrients 10, 1531.
78. Ivory K, Prieto E, Spinks C, et al. (2017) Selenium supplemen-
tation has beneficial and detrimental effects on immunity to
influenza vaccine in older adults. Clin Nutr 36, 407–415.
79. Steinbrenner H, Al-Quraishy S, Dkhil MA, et al. (2015) Dietary
selenium in adjuvant therapy of viral and bacterial infections.
Adv Nutr 6, 73–82.
80. Lee BC, Peterfi Z, Hoffmann FW, et al. (2013) MsrB1 and
MICALs regulate actin assembly and macrophage function
via reversible stereoselective methionine oxidation. Mol Cell
51, 397–404.
81. Lee BC, Lee SG, Choo MK, et al. (2017) Selenoprotein MsrB1
promotes anti-inflammatory cytokine gene expression inmac-
rophages and controls immune response in vivo. Sci Rep 7,
5119.
82. Hesse-Bahr K, Dreher I & Kohrle J (2000) The influence of the
cytokines IL-1beta and INFgamma on the expression of sele-
noproteins in the human hepatocarcinoma cell line HepG2.
Biofactors 11, 83–85.
83. Stefanowicz F, Gashut RA, Talwar D, et al. (2014) Assessment
of plasma and red cell trace element concentrations, disease
severity, and outcome in patients with critical illness. J Crit
Care 29, 214–218.
84. Li S, Banuelos GS, Wu L, et al. (2014) The changing selenium
nutritional status of Chinese residents.Nutrients 6, 1103–1114.
85. Zhang J, Taylor EW, Bennett K, et al. (2020) Association
between regional selenium status and reported outcome of
COVID-19 cases in China. Am J Clin Nutr 111, 1297–1299.
86. Barazzoni R, Bischoff SC, Breda J, et al. (2020) ESPEN expert
statements and practical guidance for nutritional management
of individuals with SARS-CoV-2 infection. Clin Nutr 39,
1631–1638.
87. Semba RD & Tang AM (1999) Micronutrients and the patho-
genesis of human immunodeficiency virus infection. Br J
Nutr 81, 181–189.
88. Zhang L & Liu Y (2020) Potential interventions for novel
coronavirus in China: a systematic review. J Med Virol 92,
479–490.
89. Kassir R (2020) Risk of COVID-19 for patients with obesity.
Obes Rev 21, e13034.
90. Peng YD, Meng K, Guan HQ, et al. (2020) Clinical character-
istics and outcomes of 112 cardiovascular disease patients
infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za
Zhi 48, E004.
91. Li MY, Li L, Zhang Y, et al. (2020) Expression of the SARS-
CoV-2 cell receptor gene ACE2 in a wide variety of human
tissues. Infect Dis Poverty 9, 45–52.
92. Pinheiro TA, Barcala-Jorge AS, Andrade JMO, et al. (2017)
Obesity and malnutrition similarly alter the renin–angiotensin








bridge.org/core . Robert G
ordon U
niversity , on 15 Feb 2021 at 09:30:20 , subject to the Cam
bridge Core term






system and inflammation in mice and human adipose. J Nutr
Biochem 48, 74–82.
93. Milner JJ, Rebeles J, Dhungana S, et al. (2015) Obesity
increases mortality and modulates the lung metabolome
during pandemic H1N1 influenza virus infection in mice.
J Immunol 194, 4846–4859.
94. Maier HE, Lopez R, Sanchez N, et al. (2018) Obesity increases
the duration of influenza a virus shedding in adults. J Infect Dis
218, 1378–1382.
95. Patel AB & Verma A (2020) COVID-19 and angiotensin-
converting enzyme inhibitors and angiotensin receptor
blockers: what is the evidence? JAMA 323, 1769–1770.
96. Tinkov AA, Ajsuvakova OP, Filippini T, et al. (2020) Selenium
and selenoproteins in adipose tissue physiology and obesity.
Biomolecules 10, 658.
97. Azad GK & Tomar RS (2014) Ebselen, a promising antioxidant
drug: mechanisms of action and targets of biological path-
ways. Mol Biol Rep 41, 4865–4879.
98. Jin Z, Du X, Xu Y, et al. (2020) Structure of Mpro from SARS-
CoV-2 and discovery of its inhibitors. Nature (London) 582,
289–293.
99. Sies H & Parnham MJ (2020) Potential therapeutic use of
ebselen for COVID-19 and other respiratory viral infections.
Free Radic Biol Med 156, 107–112.
100. Kil J, Lobarinas E, Spankovich C, et al. (2017) Safety and effi-
cacy of ebselen for the prevention of noise-induced hearing
loss: a randomised, double-blind, placebo-controlled, phase
2 trial. Lancet 390, 969–979.
101. Masaki C, Sharpley AL, Cooper CM, et al. (2016) Effects of
the potential lithium-mimetic, ebselen, on impulsivity and
emotional processing. Psychopharmacology (Berl) 233,
2655–2661.
102. Curran JE, Jowett JB, Elliott KS, et al. (2005) Genetic variation
in selenoprotein S influences inflammatory response. Nat
Genet 37, 1234–1241.
103. Crosley LK, Bashir S, Nicol F, et al. (2013) The single-
nucleotide polymorphism (GPX4c718t) in the glutathione
peroxidase 4 gene influences endothelial cell function: inter-
action with selenium and fatty acids. Mol Nutr Food Res 57,
2185–2194.
104. Nogales A & DeDiego M (2019) Host single nucleotide poly-
morphisms modulating influenza A virus disease in humans.
Pathogens 8, 168.
105. Wada M, Lokugamage KG, Nakagawa K, et al. (2018)
Interplay between coronavirus, a cytoplasmic RNA virus,
and nonsense-mediated mRNA decay pathway. Proc Natl
Acad Sci U S A 115, E10157–E10166.
106. Seyedali A & Berry MJ (2014) Nonsense-mediated decay
factors are involved in the regulation of selenoprotein
mRNA levels during selenium deficiency. RNA 20, 1248–1256.
107. Zupanic A, Meplan C, Huguenin GV, et al. (2016) Modeling
and gene knockdown to assess the contribution of non-
sense-mediated decay, premature termination, and selenocys-
teine insertion to the selenoprotein hierarchy. RNA 22,
1076–1084.
108. Avery JC & Hoffmann PR (2018) Selenium, selenoproteins,
and immunity. Nutrients 10, 1203.
109. Calder PC, Carr AC, Gombart AF, et al. (2020) Optimal nutri-
tional status for a well-functioning immune system is an
important factor to protect against viral infections. Nutrients
12, 1181.
110. Gombart AF, Pierre A & Maggini S (2020) A review of micro-
nutrients and the immune system-working in harmony to
reduce the risk of infection. Nutrients 12, 236.








bridge.org/core . Robert G
ordon U
niversity , on 15 Feb 2021 at 09:30:20 , subject to the Cam
bridge Core term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114520003128
